Chronic Lymphocytic Leukemia
The following MCCRC cancer treatment clinical trials are currently active. You may click on the trial number to link to a detailed description on PDQ, the National Cancer Institute's Web site for clinical trials.
| RC0783 | Randomized Phase II Trial of Pentostatin, Cyclophosphamide, and Rituximab With or Without Concurrent Avastin for Previously Untreated B-Chronic Lymphocytic Leukemia (CLL) |
For more information, please discuss these trials with your physician, contact the Operations Office or contact an MCCRC treating location near you.